MH Dxs are becoming trendy labels, that much is certain. There’s a perception of “being” or “having” a Dx instead of “doing” it. So greater identification but not necessarily greater treatment.

There’s less stigma, for sure. Access to care seems to be increasing. Public funding is essential for accessible treatment.

It’s also worth noting that with the AI BF stuff, you’re dealing with populations that might not even be seeking treatment to begin with